Aisling Capital’s Ambit Biosciences Corp AMBI Stock Holding History
Bought
Maintained
Sold
Aisling Capital's AMBI Position: Q4 2014 in Review
Aisling Capital sold out of Ambit Biosciences Corp (AMBI) in Q4 2014, closing a stake of 1,650,156 shares — an estimated $25.4M sold.
Aisling Capital first reported a position in AMBI in Q2 2014 and held it in 2 quarters. The position peaked at $25.4M in Q3 2014. 0 funds tracked by Wall St. Rank hold AMBI as of Q4 2014.
- Aisling Capital reported no remaining Ambit Biosciences Corp position as of Q4 2014 after selling out during the quarter.
- Aisling Capital sold 1,650,156 Ambit Biosciences Corp shares in Q4 2014, an estimated $25.4M.
- Aisling Capital first reported a position in Ambit Biosciences Corp in Q2 2014 and held it in 2 quarters.
- Aisling Capital's Ambit Biosciences Corp position peaked at $25.4M in Q3 2014.
- 0 funds tracked by Wall St. Rank held Ambit Biosciences Corp as of Q4 2014.
Based on Aisling Capital's 13F filing for Q4 2014, filed 13 Feb 2015.